Skip to main content
Lipella Pharmaceuticals Inc. (LIPO)
NASDAQ: LIPO · IEX Real-Time Price · USD
0.440
-0.016 (-3.51%)
At close: Jul 2, 2024, 3:59 PM
0.454
+0.014 (3.16%)
After-hours: Jul 2, 2024, 4:00 PM EDT

Lipella Pharmaceuticals Revenue

Lipella Pharmaceuticals had revenue of $477.45K in the twelve months ending March 31, 2024, with 77.45% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $145.88K with 23.58% year-over-year growth. In the year 2023, Lipella Pharmaceuticals had annual revenue of $449.62K with 144.15% growth.

Revenue (ttm)
$477.45K
Revenue Growth
+77.45%
P/S Ratio
7.30
Revenue / Employee
$95,490
Employees
5
Market Cap
3.48M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023449.62K265.46K144.15%
Dec 31, 2022184.16K-75.19K-28.99%
Dec 31, 2021259.35K-702.34K-73.03%
Dec 31, 2020961.68K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

LIPO News

More News